Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is an increasingly recognized disorder associated with high mortality rates. The pathomechanisms of CUA are only partially understood ...

Cisplatin chemotherapy and surgery are effective treatments for children with standard-risk hepatoblastoma but may cause considerable and irreversible hearing loss. This trial compared cisplatin with ...

Thiosulfate was oxidized stoichiometrically to tetrathionate during growth on glucose by Klebsiella aerogenes, Bacillus globigii, B. megaterium, Pseudomonas putida, two strains each of P. fluorescens ...

Metallic gold is known for its electrochemical nobility, and resulting lack of reactivity. Thus, it is usually accepted to be a non-allergenic metal. For this reason, contact dermatitis due to gold ...

Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies Thirty-one articles were summarized. Overall, systemic STS ...

Please provide your email address to receive an email when new articles are posted on . AUSTIN, Texas — Use of sodium thiosulfate to treat calciphylaxis in patients on peritoneal dialysis can be ...

The US Food and Drug Administration (FDA) has approved sodium thiosulfate (Pedmark, Fennec Pharmaceuticals) injection to reduce the risk for ototoxicity associated with cisplatin in pediatric patients ...

Vials of drug Currently, there is no approved therapy for calciphylaxis. Intravenous sodium thiosulfate does not improve skin lesions or reduce the risk of dying from calciphylaxis, a rare but ...

Sodium thiosulfate showed no benefits for reducing injury to damaged areas of heart muscle following a heart attack, in a study presented at the American College of Cardiology’s 71 st Annual ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Sodium thiosulfate, administered before and after reperfusion for STEMI, did not improve infarct ...

There is a simple discount patient access scheme for anhydrous sodium thiosulfate. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can ...